- July 08, 2025Source: Yale Ventures
Eight Translational Biotech Projects Selected for 2025 Blavatnik Accelerator Awards
- July 08, 2025
Forray Appointed Associate Dean and Director of the Office for Women in Medicine and Science
- July 08, 2025
Cartagena Appointed Clinical Director of Yale Psycho-Oncology Program
- July 07, 2025
International Exchange Fosters Clinical and Research Collaboration
- July 07, 2025
Yale Cancer Center Announces Cancer Care Equity Awards
- July 03, 2025Source: WNPR CT Public Radio (with Dr. Rachel Greenup)
Medicaid changes poised to cut access for cancer patients, CT expert says
- July 03, 2025Source: PBS Medical Stories
Passion Over Cancer — Neuroendocrine Tumors (NETs)
- July 02, 2025
Researchers Aim to Adapt Metastatic Breast Cancer Therapy as Tumors Change
Yale Cancer Center
Yale Cancer Center combines a tradition of innovative cancer treatment and quality care for our patients. A National Cancer Institute (NCI) designated comprehensive cancer center for 50 years, Yale Cancer Center is one of only 57 such Centers in the nation. Yale Cancer Center is a collaboration between nationally and internationally renowned scientists and physicians at Yale School of Medicine and Smilow Cancer Hospital. This partnership enables the Center to provide the best approaches for prevention, detection, diagnosis, and treatment for cancer.
Choosing a comprehensive cancer center for your care can have profound implications for your treatment...
In the fight against cancer, Yale has been at the forefront of understanding the fundamental mechanisms of cancer biology and in developing effective therapies for cancer treatment.
Search Yale Cancer Center's Clinical Trials
Clinical trials are currently offered to our patients in all disease areas, including Phase I clinical trials for advanced and metastatic disease.